UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

Journal of acquired immune deficiency syndromes (1999), 2023-05, Vol.93 (1), p.42-46

2023

Volltextzugriff (PDF)

The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis

The Pediatric infectious disease journal, 2023-11, Vol.42 (11), p.1017-1020

2023

Volltextzugriff (PDF)

Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children

Journal of the Pediatric Infectious Diseases Society, 2019-11, Vol.8 (5), p.433-438

2019

Volltextzugriff (PDF)

The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008-2013)

The Pediatric infectious disease journal, 2016-04, Vol.35 (4), p.407-413

2016

Volltextzugriff (PDF)

Bacteremia in previously healthy children in Emergency Departments: clinical and microbiological characteristics and outcome

European journal of clinical microbiology & infectious diseases, 2015-03, Vol.34 (3), p.453-460

2015

Volltextzugriff (PDF)

Pediatric drug-resistant tuberculosis in Madrid: family matters

The Pediatric infectious disease journal, 2014-04, Vol.33 (4), p.345-350

2014

Volltextzugriff (PDF)

Features of COVID-19 in Children During the Omicron Wave Compared With Previous Waves in Madrid, Spain

The Pediatric infectious disease journal, 2022-05, Vol.41 (5), p.e249-e251

2022

Volltextzugriff (PDF)

Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)

European journal of pediatrics, 2022-06, Vol.181 (6), p.2343-2354

2022

Volltextzugriff (PDF)

Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-02, Vol.41 (2), p.111-122

2023

Volltextzugriff (PDF)

Harmonisation preserves research resources

The Lancet infectious diseases, 2021-04, Vol.21 (4), p.e71-e71

2021

Volltextzugriff (PDF)

Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

Frontiers in immunology, 2022-05, Vol.13, p.875692-875692

2022

Volltextzugriff (PDF)

Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children

Journal of acquired immune deficiency syndromes (1999), 2018-10, Vol.79 (2), p.269-276

2018

Volltextzugriff (PDF)

A Tool to Distinguish Viral From Bacterial Pneumonia

The Pediatric infectious disease journal, 2022-01, Vol.41 (1), p.31-36

2022

Volltextzugriff (PDF)

Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections

European journal of pediatrics, 2024-02, Vol.183 (2), p.915-927

2024

Volltextzugriff (PDF)

Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis

European journal of pediatrics, 2023-09, Vol.182 (9), p.4271-4284

2023

Volltextzugriff (PDF)

QuantiFERON-TB Gold Plus Assay Specificity in Children and Adolescents With Suspected Tuberculosis-A Multicenter Cross-sectional Study in Spain

The Pediatric infectious disease journal, 2021-09, Vol.40 (9), p.e348-e351

2021

Volltextzugriff (PDF)

Comparison of Mycobacterium lentiflavum and Mycobacterium avium-intracellulare complex lymphadenitis

The Pediatric infectious disease journal, 2014-01, Vol.33 (1), p.28-34

2014

Volltextzugriff (PDF)

Oral Versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom?

The Pediatric infectious disease journal, 2022-09, Vol.41 (9), p.e351-e357

2022

Volltextzugriff (PDF)

The CARMA Study: Early Infant Antiretroviral Therapy—Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later

Journal of the Pediatric Infectious Diseases Society, 2021-04, Vol.10 (3), p.295-301

2021

Volltextzugriff (PDF)

Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

The Pediatric infectious disease journal, 2022-05, Vol.41 (5), p.e235-e242

2022

Volltextzugriff (PDF)

Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth

Journal of acquired immune deficiency syndromes (1999), 2019-12, Vol.82 (5), p.483-490

2019

Volltextzugriff (PDF)

Complications of Pneumococcal Bacteremia After Thirteen-valent Conjugate Vaccine Withdrawal

The Pediatric infectious disease journal, 2016-12, Vol.35 (12), p.1281-1287

2016

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(38)

Sprache

Englisch
(37)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis

Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children

The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008-2013)

Bacteremia in previously healthy children in Emergency Departments: clinical and microbiological characteristics and outcome

Pediatric drug-resistant tuberculosis in Madrid: family matters

Features of COVID-19 in Children During the Omicron Wave Compared With Previous Waves in Madrid, Spain

Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)

Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

Harmonisation preserves research resources

Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children

A Tool to Distinguish Viral From Bacterial Pneumonia

Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections

Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis

A Bayesian Model to Predict COVID-19 Severity in Children

QuantiFERON-TB Gold Plus Assay Specificity in Children and Adolescents With Suspected Tuberculosis-A Multicenter Cross-sectional Study in Spain

Comparison of Mycobacterium lentiflavum and Mycobacterium avium-intracellulare complex lymphadenitis

Oral Versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom?

The CARMA Study: Early Infant Antiretroviral Therapy—Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later

Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth

Complications of Pneumococcal Bacteremia After Thirteen-valent Conjugate Vaccine Withdrawal

Aktive Filter

Suchergebnisse filtern